Tissue distribution of LY231617, an antioxidant with neuroprotectant activity, in the rat.
The tissue distribution of a butylated phenol antioxidant, LY231617, which has been shown to exert potent neuroprotection action was examined. Preliminary pharmacokinetic examination suggests that LY231617 was eliminated in a biphasic fashion after iv administration to the rat with a distribution half-life of 5 min and an elimination half-life of close to 2.5 h. The volume of distribution of the compound was large (7.4 L), consistent with its lipophilic structure. Dosing paradigms that have historically resulted in pharmacologically relevant activity were examined and were found to generate brain tissue levels of LY231617 of approximately 45 micrograms/g.
Brewster
M E
ME
Pharmos Corporation, Alachua, FL 32615, USA.
Anderson
W R
WR
Estes
K S
KS
Bodor
N S
NS
Pop
E
E
Panetta
J A
JA
D000818:Animals; D000975:Antioxidants / Q000493:pharmacokinetics / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D002084:Butylated Hydroxytoluene / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D008099:Liver / Q000378:metabolism; D051379:Mice; D010599:Pharmacokinetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D014018:Tissue Distribution
D000975:Antioxidants; D002084:Butylated Hydroxytoluene; C081064:LY 231617